Institutional investors purchased a net $3.9 million shares of ILMN during the quarter ended June 2015 and now own 99.25% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 1.4 Million shares of Illumina Inc
STANDARD LIFE INVESTMENTS LTD. Bought 56.0 Thousand shares of Illumina Inc
STOREBRAND ASSET MANAGEMENT AS Bought 6.3 Thousand shares of Illumina Inc